Glp1r agonist and SGLT-2 inhibitor combination therapy

TW202635298APending Publication Date: 2026-09-01ASTRAZENECA AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114142359
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-01
Filing Date
2025-10-31
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074558_001
    Figure TWG2TA001074558_001
  • Figure TWG2TA001074558_002
    Figure TWG2TA001074558_002
  • Figure TWG2TA001074558_003
    Figure TWG2TA001074558_003
Patent Text Reader

Abstract

The specification relates to the co- administration of small molecule, once-daily, oral glucagon-like peptide-1 receptor agonists and SGLT-2 inhibitors.
Need to check novelty before this filing date? Find Prior Art